0
8
-Amino-2 -deoxyadenosine
199
ꢀ
60 C for 16 h. The solution was cooled and evaporated to dryness. The resulting
product was crystallized from water-methanol giving 130 mg (59% yield) of a white
ꢁ
1
solid. UV (max, pH 6.5) 284 nm. IR (KBr, cm ): intense bands at 2154 and 2043.
1
H-NMR (DMSO-d ): 8.05 (s, 1H, H-2), 7.31 (br s, 2H, amino), 5.60 (d, 1H,
6
0
0
OH), 5.38 (m, 2H, OH and H-1 ), 5.15 (d, 1H, OH), 4.84 (m, 1H, H-2 ), 4.18 (m,
1
0 0 0
H, H-3 ), 3.9 (m, 1H, H-4 ), 3.58 (m, 2H, H-5 ). C-NMR (DMSO-d ): 154.7
6
13
0
0
(
C-6), 156.8 (C-2), 149.6 (C-4), 144.6 (C-8), 117.5 (C-5), 87.8 (C-1 ), 86.5 (C-4 ),
0
0
0
7
3
1.5 (C-3 ), 71.0 (C-2 ), 62.3 (C-5 ). MS (electrospray) calculated for C H N O
12
1
0
8
4
þ
08.3. Found: 309.8 (M þ H ).
6-Azido-2-amino-9-b-D-ribofuranosylpurine (8). 6-Chloro-2-amino-9-b-D-ribo-
furanosylpurine (300 mg, 1 mmol) was treated with 211 mg (3 mmol) of sodium azide
ꢀ
in 7 mL of DMF at 60 C for 16 h. The solution was cooled and evaporated to dry-
ness. The resulting product was crystallized from water-methanol giving 200 mg
ꢁ
1
65% yield) of a white solid. UV (max, pH 6.5) 270, 300 nm. IR (KBr, cm ): absence
(
of bands in the region 2200–2000, intense band at 1694. H-NMR (DMSO-d ): 8.4
1
6
0
(
(
m, 3H, H-8 and amino), 5.91 (d, 1H, H-1 ), 5.45 (d, 1H, OH), 5.20 (d, 1H, OH), 5.02
0
0
0
t, 1H, OH), 4.5 (m, 1H, H-2 ), 4.18 (m, 1H, H-3 ), 3.9 (m, 1H, H-4 ), 3.6 (m, 2H,
13
H-5 ). C-NMR (DMSO-d ): 146.3 (C-6), 145.1 (C-2), 144.1 (C-4), 138.5 (C-8),
6
0
0
0
0
0
0
1
12.4 (C-5), 87.3 (C-1 ), 85.7 (C-4 ), 74.3 (C-3 ), 70.2 (C-2 ), 61.4 (C-5 ). MS (electro-
þ
spray) calculated for C H N O 308.3. Found: 309.0 (M þ H ).
1
0
12
8
4
6-Azido-9-b-D-ribofuranosylpurine (10). 6-Chloro-9-b-D-ribofuranosylpurine
(
500 mg, 1.75 mmol) was treated with 357 mg (5.2 mmol) of sodium azide in 10 mL
ꢀ
of DMF at 60 C for 16 h. The solution was cooled and concentrated to dryness.
The resulting product was crystallized from water-methanol giving 110 mg (21%
ꢁ
1
yield) of a white solid. UV (max, pH 6.5) 290 nm. IR (KBr, cm ): absence of bands
1
in the region 2200–2000, intense band at 1645. H-NMR (DMSO-d ): 10.1 (s 1H),
6
0
8.9 (s, 1H), 6.11 (d, 1H, H-1 ), 5.62 (d, 1H, OH), 5.29 (d, 1H, OH), 5.1 (t, 1H,
OH), 4.53 (m, 1H, H-2 ), 4.15 (m, 1H, H-3 ), 3.98 (m, 1H, H-4 ), 3.64 (m, 2H,
13
H-5 ). C-NMR (DMSO-d ): 145.6 (C-6), 142.8 (C-2), 142.1 (C-4), 136.3 (C-8),
0
0
0
0
6
0
0
0
0
0
1
21 (C-5), 88.5 (C-1 ), 85.9 (C-4 ), 74.8 (C-3 ), 70.2 (C-2 ), 61.1 (C-5 ). MS (electro-
þ
spray) calculated for C H N O 293.2. Found: 293.9 (M þ H ).
1
0
11
7
4
Treatment of Ribonucleosides Carrying Azido Groups with Methylamine. To
0 mg aliquots of azido-ribonucleosides (6, 8, 10) in screw-cap tubes was added
mL of 40% aqueous methylamine. The mixtures were heated to 60 C for a period
5
3
ꢀ
of time between 16 and 48 h, allowed to cool to room temperature and evaporated to
dryness. The residues were analysed by HPLC as described above. Retention time
(UV maxima) for compound 6: 9.6 min (284 nm); for compound 7: 6.4 min
(272 nm); for compound 8: 7.5 min (270, 300 nm); for compound 9: 2.7 min
(242 nm); for compound 10: 8.2 min (290 nm) and for compound 11: 3.8 min
(250 nm).
The reaction with compound 6 was completed after 16 h, giving one single pro-
1
duct that was characterized as 8-aminoadenosine (7) . H-NMR (DMSO-d ): 7.89
4 1
6
0
0
(
(
s, 1H, H-2), 6.54 (m, 2H, amino), 5.82 (d, 1H, H-1 ), 4.64 (m, 1H, H-2 ), 4.12
0
0
0
13
m, 1H, H-3 ), 3.9 (m, 1H, H-4 ), 3.58 (m, 2H, H-5 ). C-NMR (DMSO-d ): 152.6
6